Natural Product: NPC611914

Natural Product IDNPC611914
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
NSKGQURZWSPSBC-VVPCINPTSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL221572
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey NSKGQURZWSPSBC-VVPCINPTSA-N
Standard InCHI InChI=1S/C17H34N4O10/c18-2-6-10(24)12(26)8(21)16(28-6)30-14-5(20)1-4(19)9(23)15(14)31-17-13(27)11(25)7(3-22)29-17/h4-17,22-27H,1-3,18-21H2/t4-,5+,6-,7-,8-,9+,10-,11-,12-,13-,14-,15-,16-,17+/m1/s1
SMILES NC[C@H]1O[C@H](O[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O

  Calculated Properties

Physi-Chem Properties

MedChem Properties

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

ADMET: Distribution

ADMET: Metabolism

ADMET: Excretion

ADMET: Toxicity

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24176 Streptomyces fradiae Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[10757717]
NPO3457 Streptomyces diastaticus Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[8904845]
NPO3457 Streptomyces diastaticus Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO24176 Streptomyces fradiae Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO27507 Streptomyces ribosidificus Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO48996 Streptomyces ribosidificus ATCC 21294 Genus Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO42284 Streptomyces ribosidificus SF-733 Genus Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO24176 Streptomyces fradiae Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]
NPO3457 Streptomyces diastaticus Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]
NPO27507 Streptomyces ribosidificus Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = -5.95 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = -3.61 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT29454 Single protein Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Homo sapiens Inhibition = 1.755 % PMID[38318365]
NPT26263 Single protein Aminoglycoside 3'-phosphotransferase type IIb Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG12228) Kcat/Km = 190000.0 /M/s PMID[17088479]
NPT28792 Nucleic-acid Nucleic Acid n.a. Kd = 1700.0 nM PMID[19445516]
NPT28792 Nucleic-acid Nucleic Acid n.a. Activity n.a. n.a. n.a. PMID[17875999]
NPT28461 Nucleic-acid Ribosomal RNA A-site n.a. Kd = 25000.0 nM PMID[11206440]
NPT28461 Nucleic-acid Ribosomal RNA A-site n.a. IC50 = 90.0 nM PMID[27509271]
NPT28461 Nucleic-acid Ribosomal RNA A-site n.a. Kd = 16350.0 nM PMID[16942021]
NPT28792 Nucleic-acid Nucleic Acid n.a. MIC = 100000.0 nM PMID[9457241]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 IC50 > 20000.0 nM Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity
NPT1033 Organism Enterobacter cloacae Enterobacter cloacae MIC > 64.0 ug.mL-1 DOI[10.1039/C5MD00429B]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 IC50 > 19952.62 nM Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity
NPT28438 Unchecked Unchecked n.a. Activity n.a. n.a. n.a. DOI[10.1039/C5MD00496A]
NPT28438 Unchecked Unchecked n.a. IC50 = 115810.0 nM PMID[27509271]
NPT1122 Organism Haemophilus influenzae Haemophilus influenzae MIC = 8.0 ug.mL-1 PMID[27509271]
NPT28438 Unchecked Unchecked n.a. Ratio IC50 = 1286.78 n.a. PMID[27509271]
NPT1264 Organism Burkholderia cepacia Burkholderia cepacia MIC > 32.0 ug.mL-1 PMID[27509271]
NPT2905 Organism Nocardia farcinica Nocardia farcinica MIC > 1024.0 ug.mL-1 PMID[20308368]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MIC = 8.0 ug.mL-1 PMID[27509271]
NPT2905 Organism Nocardia farcinica Nocardia farcinica MIC = 256.0 ug.mL-1 PMID[20308368]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MIC > 32.0 ug.mL-1 PMID[27509271]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MIC = 2.0 ug.mL-1 DOI[10.1039/C5MD00429B]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 64.0 ug.mL-1 DOI[10.1039/C5MD00429B]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 64.0 ug.mL-1 PMID[24900282]
NPT19 Organism Escherichia coli Escherichia coli MIC >= 32.0 ug.mL-1 PMID[17870543]
NPT19 Organism Escherichia coli Escherichia coli MIC = 8.0 ug.mL-1 PMID[17870543]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 8.0 ug.mL-1 PMID[24900282]
NPT19 Organism Escherichia coli Escherichia coli MIC > 256.0 ug.mL-1 PMID[17875999]
NPT19 Organism Escherichia coli Escherichia coli MIC = 12.0 ug.mL-1 PMID[17088479]
NPT19 Organism Escherichia coli Escherichia coli MIC = 768.0 ug.mL-1 PMID[17088479]
NPT19 Organism Escherichia coli Escherichia coli MIC = 8.0 ug.mL-1 DOI[10.1039/C5MD00429B]
NPT19 Organism Escherichia coli Escherichia coli MIC > 64.0 ug.mL-1 DOI[10.1039/C5MD00429B]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 64.0 ug.mL-1 DOI[10.1039/C5MD00429B]
NPT19 Organism Escherichia coli Escherichia coli MIC = 4.0 ug.mL-1 PMID[17870543]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 32.0 ug.mL-1 PMID[27509271]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 16.0 ug.mL-1 DOI[10.1039/C5MD00429B]
NPT19 Organism Escherichia coli Escherichia coli MIC = 0.5 ug.mL-1 PMID[17875999]
NPT19 Organism Escherichia coli Escherichia coli MIC > 32.0 ug.mL-1 PMID[27509271]
NPT19 Organism Escherichia coli Escherichia coli MIC = 4.0 ug.mL-1 PMID[27509271]
NPT19 Organism Escherichia coli Escherichia coli MIC = 0.25 ug.mL-1 PMID[17875999]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 384.0 ug.mL-1 PMID[17088479]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii MIC = 8.0 ug.mL-1 DOI[10.1039/C5MD00429B]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii MIC > 64.0 ug.mL-1 DOI[10.1039/C5MD00429B]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii MIC = 16.0 ug.mL-1 PMID[27509271]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference
Homo sapiens n.a. Vdss = 0.25 L.kg-1 PMID[18426954]
Homo sapiens n.a. CL = 1.5 mL.min-1.kg-1 PMID[18426954]
Escherichia coli n.a. Uptake at C50 = 2.6 n.a. PMID[3543366]
Homo sapiens n.a. T1/2 = 2.5 hr PMID[18426954]
Homo sapiens n.a. MRT = 2.8 hr PMID[18426954]





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference
- Rattus norvegicus LD50 > 10000.0 mg/kg ToxVal
- Mus musculus LD50 = 7000.0 mg/kg ToxVal

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC611914 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.82 Intermediate Similarity NPC606532
0.7818 Intermediate Similarity NPC611963
0.7586 Intermediate Similarity NPC611441
0.566 Remote Similarity NPC605197
0.5574 Remote Similarity NPC611754
0.5342 Remote Similarity NPC602333
0.5152 Remote Similarity NPC607776

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC611914 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD2698 Approved
0.7818 Intermediate Similarity NPD5798 Phase 3
0.7586 Intermediate Similarity NPD5795 Phase 4
0.7586 Intermediate Similarity NPD5796 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD5797 Approved
0.6984 Remote Similarity NPD5794 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data